Ozempic Among the Next Drugs Up for Medicare Price Negotiations
Ozempic, Wegovy and Other New Drugs Are Selected for Medicare's Price Negotiations
Medicare targets 15 more drugs for price negotiations — including Ozempic
UnitedHealth books better-than-expected fourth-quarter profit
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt
UnitedHealth fights back: Blame drugmakers for high costs, not the ‘middlemen.’
UnitedHealth Group’s stock sinks after profit beat expectations but revenue missed for the first time in more than four years.
Wall Street Journal9d
Shilpa Medicare Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Wall Street Journal11d
Tian An Medicare Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
MarketWatch3d
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company. The U.S ...
I’m blindsided by extra Medicare charges because of my income. How do I avoid this situation?
A reader is trying to plan ahead to avoid the dreaded surcharges that can come out of your Social Security check.
UnitedHealth’s Earnings Point to High Medical Costs in 2025. Health Insurer Stocks Sink.
Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.
Healthline6d
Medicare and Prescription Drugs: What’s Covered?
The four major Medicare parts (A, B, C, D) all offer some prescription drug coverage. Medicare Part D offers the most extensive outpatient prescription drug coverage ...
UnitedHealth CEO Defends Company As Stock Sinks on Earnings
Adjusted per-share earnings in the fourth quarter for UnitedHealth top analysts’ estimates but revenue comes up short.
UnitedHealth fights back: Blame drugmakers for high costs, not the 'middlemen.'
On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian Thompson, who headed the company's UnitedHealthcare unit. See: FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%.
UnitedHealth tops profit forecasts but medical costs linger for health care giant
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but revenue fell short as challenges like Medicare funding cuts and a Medicaid enrollment drop hurt. Shares of the health care giant slid early Thursday after it released its first financial report since the brazen shooting of one of its executives outside a New York City hotel touched a national nerve and brought to the surface American frustration over health care access.